Ab externo Schlemm's canal (SC) surgery (e.g., viscocanalostomy and canaloplasty) is a valuable alternative to
glaucoma filtration surgery. It targets the abnormally high resistance to outflow in the trabecular meshwork (TM) and reestablishes the physiologic outflow system. In viscocanalostomy, viscoelastic substance is injected to dilate SC, which in turn leads to microdisruptions of the inner wall. In canaloplasty, the additional intracanalicular
stent (
suture or Stegmann Canal Expander®) keeps the canal patent and enhances the circumferential flow. A prerequisite for these procedures to work is the integrity of the distal outflow system, which can be evaluated by 2 clinical tests before surgery: provocative gonioscopy with blood reflux, and
fluorescein channelography. Ab externo SC surgery is suitable for
open-angle glaucoma, but also for
angle closure glaucoma in combination with
cataract extraction. Intraocular pressure reduction to the mid-teens for viscocanalostomy and to the lower-teens for canaloplasty can be expected. The majority of complications seen in
filtering surgery are largely eliminated by the nonpenetrating and
bleb-independent approach.
Postoperative care is minimal as no
bleb management such as
needling is required, and hypotony-related complications are largely avoided by the intrinsic resistance of the physiologic outflow system. With its efficacy and high safety profile, ab externo SC surgery will continue to play an increasing role and will change the current concept of
glaucoma surgery towards earlier intervention. Surgeons will be well advised to implement these
antimetabolite-free procedures into their armamentarium to meet the expectations of the demanding
glaucoma patient.